Intercept Pharmaceuticals: Q1 Earnings Insights

Intercept Pharmaceuticals ICPT reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Intercept Pharmaceuticals beat estimated earnings by 35.56%, reporting an EPS of $-0.58 versus an estimate of $-0.9.

Revenue was up $6.92 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.13 which was followed by a 3.98% increase in the share price the next day.

Here's a look at Intercept Pharmaceuticals's past performance:

To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.